fbpx
  • Home
  • Study Details
Open

A Multidimensional Digital Approach to Address Vaccine Hesitancy and Increase COVID-19 Vaccine Uptake among African American Young Adults in the South (Tough Talks COVID)

This project seeks to adapt and test the existing Tough Talks app to address COVID vaccine hesitancy among African American young adults (AA-YA) aged 18-29.

Age & Gender

  • 18 years ~ 29 years
  • Male, Female, Gender Inclusive

Location

Alabama, Georgia, North Carolina (Statewide)

What will be asked of you

You will be asked to complete a one-time survey that will take about 45 minutes to complete.

Incentives

$20 for taking the survey. After completing the survey, you will be entered in a drawing and could win up to $250.

Total length of participation:
45 minutes.

Looking for Healthy Volunteers

Requirements for healthy volunteers are different than for those with a specific condition. If you are interested in becoming a healthy volunteer for this study, use the below categories to determine if you are able to participate.

Able to participate:

  • You are 18-29 years old,
  • Black or African American,
  • and living in NC, GA, or AL.

Not eligible if:

  • You are younger than 18 or older than 29, are not Black or African American, or live outside of NC, GA or AL

Contact the Team

Visit Location

  •  Christina Toval

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Lisa Hightow-Weidman
Medicine-Infectious Diseases

Study Type

Behavioral or Social
Interventional

Study Topics

Healthy Volunteer or General Population
Minority Health
COVID-19

IRB Number

21-1746

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.